Citigroup
XGN icon

Citigroup’s Exagen XGN Stock Holding History

Citigroup’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$43.8K Buy
+5,392
New +$34.6K ﹤0.01% 4751
2025
Q4 		– Sell
-2,044
Closed -$22.5K – 6527
2025
Q3 		$22.5K Buy
+2,044
New +$18.1K ﹤0.01% 4784
2025
Q1 		– Sell
-5,582
Closed -$22.9K – 6015
2024
Q4 		$22.9K Buy
+5,582
New +$20.1K ﹤0.01% 5253
2022
Q3 		– Sell
-92
Closed -$1K – 6375
2022
Q2 		$1K Sell
92
-834
-90% -$4.86K ﹤0.01% 6110
2022
Q1 		$7K Sell
926
-1,787
-66% -$15.4K ﹤0.01% 5707
2021
Q4 		$32K Buy
2,713
+1,630
+151% +$19.1K ﹤0.01% 5247
2021
Q3 		$15K Buy
1,083
+568
+110% +$7.55K ﹤0.01% 5361
2021
Q2 		$8K Buy
515
+197
+62% +$3.02K ﹤0.01% 5747
2021
Q1 		$6K Sell
318
-598
-65% -$10.7K ﹤0.01% 5864
2020
Q4 		$12K Buy
916
+686
+298% +$9.7K ﹤0.01% 6905
2020
Q3 		$3K Sell
230
-415
-64% -$5.34K ﹤0.01% 7244
2020
Q2 		$8K Sell
645
-330
-34% -$4.46K ﹤0.01% 7148
2020
Q1 		$16K Buy
975
+311
+47% +$6.17K ﹤0.01% 6833
2019
Q4 		$17K Buy
+664
New +$11.8K ﹤0.01% 7005

Other funds holding XGN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return
Penbrook Management
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Citigroup's XGN Position: Q3 2026 in Review

Citigroup opened a new position in Exagen (XGN) in Q3 2026: 5,392 shares worth $43.8K. The stake represents ﹤0.01% of the portfolio and ranks #4751 among its holdings. This is a return to the name: Citigroup previously reported a position in XGN as recently as Q3 2025.

Citigroup first reported a position in XGN in Q4 2019 and has held it in 14 quarters since. 15 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • Citigroup held 5,392 shares of Exagen worth $43.8K as of Q3 2026.
  • Exagen was a new Citigroup position in Q3 2026.
  • Exagen made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4751 holding.
  • Citigroup first reported a position in Exagen in Q4 2019 and has held it in 14 quarters since.
  • 15 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.